help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on August 19, 2008
Journal of Clinical Endocrinology & Metabolism , doi:10.1210/jc.2008-0586
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
93/11/4282    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints, Permissions and Rights
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alkazemi, D.
Right arrow Articles by Kubow, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alkazemi, D.
Right arrow Articles by Kubow, S.

Submitted on March 13, 2008
Accepted on August 8, 2008

Oxysterol as a Marker of Atherogenic Dyslipidemia in Adolescence

Dalal Alkazemi M.Sc., Grace Egeland Ph.D., Jacob Vaya Ph.D., Sara Meltzer M.D., and Stan Kubow Ph.D.*

School of Dietetics and Human Nutrition, McGill University, Canada; Laboratory of Natural Medicinal Compounds, Migal-Galilee Technology Center, Kiryat Shmona, Israel; Department of Medicine, Division of Endocrinology and Metabolism, McGill University Health Center, Royal Victoria Hospital, Canada

* To whom correspondence should be addressed. E-mail: stan.kubow{at}mcgill.ca.

Context: Oxysterols represent potentially important oxidative stress biomarkers in adolescence.

Objective: To examine the relationship between the concentrations of serum enzymatically and non-enzymatically generated oxysterols and: (1) measures of obesity; and (2) metabolic components including insulin resistance, levels of blood pressure and serum lipids.

Design: Cross-sectional study

Setting: All subjects were examined between 2003 and 2005 at a hospital; a part of a follow-up evaluation mother-daughter pairs representing pregnancies affected or unaffected by gestational diabetes (GDM) that resulted in the deliveries in 1989–1991.

Subjects: A subset (n=89) of the total study population of 189 adolescent girls with a mean age of 15.32 ± 0.65 y and BMI: 22.54 ± 3.98 kg/m2.

Main outcome measures: Serum levels of the oxysterols 7{alpha}-hydroxy-cholesterol (7{alpha}OH), 7{beta}-hydroxycholesterol (7{beta}OH), 7-ketocholesterol (7-keto); and body mass index (BMI), HOMA-IR, fasting insulin, fasting glucose, blood pressure, and total cholesterol, non-high density lipoprotein cholesterol (non-HDL-C), low density lipoprotein cholesterol (LDL-C), high density lipoprotein cholesterol (HDL-C), triglycerides and apolipoprotein B (ApoB).

Results: Serum oxysterol concentrations in the adolescent cohort correlated positively with insulin (p<0.05), total cholesterol (p<0.05), non-HDL-C (p<0.05), LDL-C (p<0.05) and ApoB (p<0.01). ApoB and fasting insulin were found to be the major determinants of serum oxysterols after adjustment for BMI. Being a daughter of GDM-pregnancy alone did not seem to be a predisposing factor to increased oxidative stress in our cohort.

Conclusion: Serum oxysterol concentrations increase with obesity, insulin and ApoB which are established derangements associated with the metabolic syndrome.


Key words: Oxysterols • obesity • adolescence




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
S. Gallo, G. Egeland, S. Meltzer, L. Legault, and S. Kubow
Plasma Fatty Acids and Desaturase Activity Are Associated with Circulating Adiponectin in Healthy Adolescent Girls
J. Clin. Endocrinol. Metab., May 1, 2010; 95(5): 2410 - 2417.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
L. Iuliano, R. Monticolo, G. Straface, S. Zullo, F. Galli, M. Boaz, and S. Quattrucci
Association of cholesterol oxidation and abnormalities in fatty acid metabolism in cystic fibrosis
Am. J. Clinical Nutrition, September 1, 2009; 90(3): 477 - 484.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society